Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 7.6% in January

Biomerica, Inc. (NASDAQ:BMRA) was the target of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 254,500 shares, a decrease of 7.6% from the January 15th total of 275,500 shares. Based on an average daily trading volume, of 7,530,000 shares, the short-interest ratio is presently 0.0 days.

Biomerica Stock Up 24.1 %

Shares of NASDAQ BMRA opened at $1.03 on Wednesday. The firm’s 50-day moving average price is $0.46 and its two-hundred day moving average price is $0.39. Biomerica has a 52-week low of $0.24 and a 52-week high of $1.35. The stock has a market capitalization of $18.89 million, a P/E ratio of -3.03 and a beta of -0.98.

Biomerica (NASDAQ:BMRA) last announced its quarterly earnings results on Tuesday, January 14th. The company reported ($0.06) earnings per share (EPS) for the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

Hedge Funds Weigh In On Biomerica

An institutional investor recently raised its position in Biomerica stock. Granahan Investment Management LLC raised its position in shares of Biomerica, Inc. (NASDAQ:BMRA) by 24.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 658,767 shares of the company’s stock after purchasing an additional 131,306 shares during the period. Granahan Investment Management LLC owned 3.59% of Biomerica worth $198,000 at the end of the most recent quarter. Institutional investors and hedge funds own 22.28% of the company’s stock.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.